Karen M. Nichols
General Counsel bei International Society for Cellular Therapy
Profil
Karen M.
Nichols is currently the Chief Regulatory Officer at the International Society for Cellular Therapy since 2007.
Prior to this, she held the position of Vice President-Regulatory & Quality at NantKwest, Inc. and Magenta Therapeutics, Inc. Ms. Nichols completed her undergraduate and graduate degrees from The State University of New York and also holds a graduate degree from Suffolk University Law School, which was conferred in 1996.
Aktive Positionen von Karen M. Nichols
| Unternehmen | Position | Beginn |
|---|---|---|
International Society for Cellular Therapy
 International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | General Counsel | 01.01.2007 |
Ehemalige bekannte Positionen von Karen M. Nichols
| Unternehmen | Position | Ende |
|---|---|---|
| MAGENTA THERAPEUTICS | General Counsel | - |
| IMMUNITYBIO, INC. | General Counsel | - |
Ausbildung von Karen M. Nichols
| The State University of New York | Graduate Degree |
| Suffolk University Law School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Commercial Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
